Literature DB >> 32065972

Cuprizone-induced oligodendrocyte loss and demyelination impairs recording performance of chronically implanted neural interfaces.

Steven M Wellman1, Kelly Guzman2, Kevin C Stieger1, Lauren E Brink2, Sadhana Sridhar3, Mitchell T Dubaniewicz4, Lehong Li4, Franca Cambi5, Takashi D Y Kozai6.   

Abstract

Biological inflammation induced during penetrating cortical injury can disrupt functional neuronal and glial activity within the cortex, resulting in potential recording failure of chronically implanted neural interfaces. Oligodendrocytes provide critical support for neuronal health and function through direct contact with neuronal soma and axons within the cortex. Given their fundamental role to regulate neuronal activity via myelin, coupled with their heightened vulnerability to metabolic brain injury due to high energetic demands, oligodendrocytes are hypothesized as a possible source of biological failure in declining recording performances of intracortical microelectrode devices. To determine the extent of their contribution to neuronal activity and function, a cuprizone-inducible model of oligodendrocyte depletion and demyelination in mice was performed prior to microelectrode implantation. At 5 weeks of cuprizone exposure, mice demonstrated significantly reduced cortical oligodendrocyte density and myelin expression. Mice were then implanted with functional recording microelectrodes in the visual cortex and neuronal activity was evaluated up to 7 weeks alongside continued cuprizone administration. Cuprizone-induced oligodendrocyte loss and demyelination was associated with significantly reduced recording performances at the onset of implantation, which remained relatively stable over time. In contast, recording performances for mice on a normal diet were intially elevated before decreasing over time to the recording level of tcuprizone-treated mice. Further electrophysiological analysis revealed deficits in multi-unit firing rates, frequency-dependent disruptions in neuronal oscillations, and altered laminar communication within the cortex of cuprizone-treated mice. Post-mortem immunohistochemistry revealed robust depletion of oligodendrocytes around implanted microelectrode arrays alongside comparable neuronal densities to control mice, suggesting that oligodendrocyte loss was a possible contributor to chronically impaired device performances. This study highlights potentially significant contributions from the oligodendrocyte lineage population concerning the biological integration and long-term functional performance of neural interfacing technology.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32065972      PMCID: PMC7540937          DOI: 10.1016/j.biomaterials.2020.119842

Source DB:  PubMed          Journal:  Biomaterials        ISSN: 0142-9612            Impact factor:   12.479


  136 in total

1.  Elastomeric and soft conducting microwires for implantable neural interfaces.

Authors:  Christi L Kolarcik; Silvia D Luebben; Shawn A Sapp; Jenna Hanner; Noah Snyder; Takashi D Y Kozai; Emily Chang; James A Nabity; Shawn T Nabity; Carl F Lagenaur; X Tracy Cui
Journal:  Soft Matter       Date:  2015-05-20       Impact factor: 3.679

2.  Oligodendrocyte vulnerability following traumatic brain injury in rats.

Authors:  George Lotocki; Juan Pablo de Rivero Vaccari; Juan de Rivero Vaccari; Ofelia Alonso; Juliana Sanchez Molano; Ryan Nixon; Padideh Safavi; W Dalton Dietrich; Helen M Bramlett
Journal:  Neurosci Lett       Date:  2011-06-06       Impact factor: 3.046

3.  Proteomic analysis of demyelinated and remyelinating brain tissue following dietary cuprizone administration.

Authors:  Sean R Werner; Joy K Saha; Carol L Broderick; Eugene Y Zhen; Richard E Higgs; Kevin L Duffin; Rosamund C Smith
Journal:  J Mol Neurosci       Date:  2010-04-17       Impact factor: 3.444

4.  Distinct superficial and deep laminar domains of activity in the visual cortex during rest and stimulation.

Authors:  Alexander Maier; Geoffrey K Adams; Christopher Aura; David A Leopold
Journal:  Front Syst Neurosci       Date:  2010-08-10

5.  Distinct profiles of myelin distribution along single axons of pyramidal neurons in the neocortex.

Authors:  Giulio Srubek Tomassy; Daniel R Berger; Hsu-Hsin Chen; Narayanan Kasthuri; Kenneth J Hayworth; Alessandro Vercelli; H Sebastian Seung; Jeff W Lichtman; Paola Arlotta
Journal:  Science       Date:  2014-04-18       Impact factor: 47.728

6.  Two-photon imaging of chronically implanted neural electrodes: Sealing methods and new insights.

Authors:  Takashi D Y Kozai; James R Eles; Alberto L Vazquez; X Tracy Cui
Journal:  J Neurosci Methods       Date:  2015-10-23       Impact factor: 2.390

Review 7.  On Myelinated Axon Plasticity and Neuronal Circuit Formation and Function.

Authors:  Rafael G Almeida; David A Lyons
Journal:  J Neurosci       Date:  2017-10-18       Impact factor: 6.167

Review 8.  Tools for probing local circuits: high-density silicon probes combined with optogenetics.

Authors:  György Buzsáki; Eran Stark; Antal Berényi; Dion Khodagholy; Daryl R Kipke; Euisik Yoon; Kensall D Wise
Journal:  Neuron       Date:  2015-04-08       Impact factor: 17.173

9.  The Absolute Number of Oligodendrocytes in the Adult Mouse Brain.

Authors:  Bruna Valério-Gomes; Daniel M Guimarães; Diego Szczupak; Roberto Lent
Journal:  Front Neuroanat       Date:  2018-10-30       Impact factor: 3.856

Review 10.  Myelin damage and repair in pathologic CNS: challenges and prospects.

Authors:  Arsalan Alizadeh; Scott M Dyck; Soheila Karimi-Abdolrezaee
Journal:  Front Mol Neurosci       Date:  2015-07-27       Impact factor: 5.639

View more
  8 in total

Review 1.  Challenges and opportunities of advanced gliomodulation technologies for excitation-inhibition balance of brain networks.

Authors:  Keying Chen; Kevin C Stieger; Takashi Dy Kozai
Journal:  Curr Opin Biotechnol       Date:  2021-11-10       Impact factor: 9.740

2.  Combination Therapy of Mesenchymal Stem Cell Transplantation and Astrocyte Ablation Improve Remyelination in a Cuprizone-Induced Demyelination Mouse Model.

Authors:  Soheila Madadi; Elham Shiri; Parichehr Pasbakhsh; Fatemeh Tahmasebi; Shokoofeh Kazemzadeh; Kazem Zibara; Iraj Ragerdi Kashani
Journal:  Mol Neurobiol       Date:  2022-09-29       Impact factor: 5.682

3.  Inhibition of Na+/H+exchanger modulates microglial activation and scar formation following microelectrode implantation.

Authors:  Mitchell Dubaniewicz; James R Eles; Stephanie Lam; Shanshan Song; Franca Cambi; Dandan Sun; Steven M Wellman; Takashi D Y Kozai
Journal:  J Neural Eng       Date:  2021-03-19       Impact factor: 5.379

4.  In vivo spatiotemporal patterns of oligodendrocyte and myelin damage at the neural electrode interface.

Authors:  Keying Chen; Steven M Wellman; Yalikun Yaxiaer; James R Eles; Takashi Dy Kozai
Journal:  Biomaterials       Date:  2020-11-23       Impact factor: 12.479

5.  More Than Cell Markers: Understanding Heterogeneous Glial Responses to Implantable Neural Devices.

Authors:  Ouzéna Bouadi; Tuan Leng Tay
Journal:  Front Cell Neurosci       Date:  2021-04-12       Impact factor: 5.505

Review 6.  Engineering strategies towards overcoming bleeding and glial scar formation around neural probes.

Authors:  Elisabeth Otte; Andreas Vlachos; Maria Asplund
Journal:  Cell Tissue Res       Date:  2022-01-14       Impact factor: 5.249

7.  Integrating Lipidomics and Transcriptomics Reveals the Crosstalk Between Oxidative Stress and Neuroinflammation in Central Nervous System Demyelination.

Authors:  Zhi-Jie Zhao; Rui-Zhe Zheng; Xiao-Jing Wang; Tong-Qi Li; Xiao-Hua Dong; Chang-Yi Zhao; Xin-Yuan Li
Journal:  Front Aging Neurosci       Date:  2022-04-25       Impact factor: 5.750

8.  Untargeted Metabolomic Profiling of Cuprizone-Induced Demyelination in Mouse Corpus Callosum by UPLC-Orbitrap/MS Reveals Potential Metabolic Biomarkers of CNS Demyelination Disorders.

Authors:  Zhijie Zhao; Tongqi Li; Xiaohua Dong; Xiaojing Wang; Zhongxiao Zhang; Changyi Zhao; Xueran Kang; Ruizhe Zheng; Xinyuan Li
Journal:  Oxid Med Cell Longev       Date:  2021-09-14       Impact factor: 6.543

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.